Singapore markets close in 2 hours 28 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
130.90+4.24 (+3.35%)
At close: 04:00PM EDT
138.69 +7.79 (+5.95%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close126.66
Open127.06
Bid130.60 x 100
Ask131.23 x 100
Day's range127.00 - 131.61
52-week range55.25 - 159.89
Volume840,602
Avg. volume854,572
Market cap12.371B
Beta (5Y monthly)0.95
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments

    CAMBRIDGE, Mass., May 01, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter 2024.

  • Business Wire

    Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., April 30, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on April 30, 2024 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 24 individuals hired by Sarepta in April 2024. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

  • Business Wire

    Sarepta Therapeutics to Announce First Quarter 2024 Financial Results

    CAMBRIDGE, Mass., April 24, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2024 financial results.